Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.44
Bid: 41.60
Ask: 41.70
Change: 0.56 (1.37%)
Spread: 0.10 (0.24%)
Open: 41.36
High: 41.70
Low: 40.84
Prev. Close: 40.88
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update

13 Jan 2020 07:00

RNS Number : 5048Z
Assura PLC
13 January 2020
 

13 January 2020

Assura plc

 

Trading Update

For the third quarter ending 31 December 2019

 

Continued strong performance

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the third quarter ending 31 December 2019.

 

Jonathan Murphy, CEO, said:

 

"Assura continued to make strong progress in the third quarter. We expanded our market-leading portfolio with the acquisition of six high-quality assets and completed our third development of the year in Stow-on-the-Wold. We also grew our immediate pipeline of acquisition and development opportunities, reinforcing what was already our strongest in 10 years, to £252 million including 13 developments currently on site."

 

"With the new Government enshrining in law increased funding for the NHS and taking forward the Health Infrastructure Plan, better primary care facilities for patients, staff and services are at the heart of the agenda. In this context, Assura is well positioned to deliver high-quality assets and value for money for the NHS."

 

Building the portfolio

·; Current portfolio of 563 properties.

·; Development completed at Stow-on-the-Wold, taking total to three completed year to date at a total cost of £11.8 million.

·; Currently on site with 13 developments at the period end with a total development cost of £66 million.

·; Six acquisitions completed in the period at a cost of £31.1 million; four disposals made for cash proceeds of £1.0 million.

 

Expanding the pipeline

·; Immediate development pipeline further increased to £90 million, up from £72 million at September 2019.

·; Immediate acquisitions pipeline further increased to £96 million, up from £65 million at September 2019.

·; Total immediate pipeline, including on site developments, worth £252 million, up from £206 million at September 2019.

 

Growing the rent roll

·; Five lease re-gears completed in the quarter taking cumulative year-to-date re-gears to 18. These leases represent £1.7 million of the Group's rent roll, adding a weighted average of 10.2 years WAULT to those 18 leases.

·; Annualised rent roll at £105.8 million taking account of additions, disposals and rent reviews.

 

Robust balance sheet

·; As at 31 December 2019 gross debt stood at £787 million with undrawn facilities of £280 million.

 

As previously announced, the quarterly dividend has been increased to 0.697 pence per share with effect from January 2020. This is equivalent to 2.788 pence per share on an annualised basis.

 

ENDS

 

 

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFO

David Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2019, Assura's property portfolio was valued at £2,039 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFLFERLEIILII
Date   Source Headline
19th Dec 20191:43 pmRNSDirector/PDMR Shareholding
19th Dec 201910:15 amRNSScrip Calculation Price
10th Dec 201911:01 amRNSNotification of Major Interests in Shares
5th Dec 20199:02 amRNSNotice of Dividend
12th Nov 20197:00 amRNSInterim Results 2019
1st Nov 20199:48 amRNSDirector Declaration
18th Oct 20194:31 pmRNSNotification of Major Interests in Shares
17th Oct 20199:46 amRNSDirector/PDMR Shareholding
14th Oct 20197:00 amRNSScrip Dividend Declaration
3rd Oct 20197:00 amRNSTrading Update
19th Sep 201910:19 amRNSScrip Calculation Price
9th Sep 201911:25 amRNSPDMR Notification
5th Sep 20197:00 amRNSNotice of Dividend
21st Aug 20194:27 pmRNSNotification of Major Interests in Shares
13th Aug 20194:10 pmRNSExercise of Nil Cost Options under PSP
9th Aug 20192:40 pmRNSAdditional Listing
8th Aug 20197:00 amRNSNote issuance
17th Jul 20193:07 pmRNSPersons Discharging Managerial Responsibilities
15th Jul 20197:00 amRNSScrip Dividend Declaration
3rd Jul 20194:03 pmRNSPDMR Notification
2nd Jul 20192:41 pmRNSResult of AGM
2nd Jul 20197:00 amRNSTrading Update
20th Jun 201911:45 amRNSScrip Calculation Price
10th Jun 20193:46 pmRNSNotification of Major Interests in Shares
6th Jun 20197:00 amRNSNotice of Dividend
5th Jun 20199:00 amRNSNotification of Major Interests in Shares
4th Jun 20193:10 pmRNSPDMR Notification
30th May 20197:00 amRNSAnnual Report and Notice of AGM
30th May 20197:00 amRNSAppointment of Non-Executive Director
21st May 20197:00 amRNSAssura Full Year Results
20th May 201910:41 amRNSDirectorate Change
17th Apr 20192:35 pmRNSPersons Discharging Managerial Responsibilities
15th Apr 20197:00 amRNSScrip Dividend Declaration
21st Mar 201912:13 pmRNSScrip Calculation Price
7th Mar 20192:23 pmRNSNotice of Dividend
14th Feb 20199:36 amRNSIssue of Consideration Shares
22nd Jan 20197:00 amRNSTrading Update
14th Jan 20197:00 amRNSScrip dividend declaration
20th Dec 201810:17 amRNSScrip Calculation Price
6th Dec 20189:30 amRNSNotice of dividend
22nd Nov 20187:00 amRNSInterim Results 2018
1st Nov 20187:00 amRNSTotal Voting Rights
15th Oct 20187:00 amRNSScrip Dividend Declaration
5th Oct 20187:00 amRNSAcquisition update
1st Oct 20187:00 amRNSTrading Update
28th Sep 20184:58 pmRNSNotification of Major Interests in Shares
20th Sep 201810:26 amRNSScrip Calculation Price
6th Sep 201811:04 amRNSNotice of Dividend
25th Jul 20181:29 pmRNSNotification of Major Interests in Shares
20th Jul 20181:38 pmRNSPDMR Notification

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.